SEC Form 4 · accession 0001562180-18-004418
ARRAY BIOPHARMA INC · ARRY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carrie Smith Cox
Director
Period of report
Nov 1, 2018
Accepted (ET)
Nov 5, 2018 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100412
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 1, 2018 | P | 3,000 | $16.8651 | A | 3,000 | D |
Table II — derivative securities
No Table II lines on this filing.